Based on finding in HCC tumor specimens, Yang et al. used CD90, a well-described liver CSC-related marker to characterize stem-like CTCs by investigation of CD45- CD90+ cells in blood samples of PLC patients. The gene discussed is PTPRC; the disease is neoplasm.